Concepedia

Publication | Closed Access

4O Nivolumab (NIVO) + ipilimumab (IPI) versus chemotherapy (chemo) as first-line (1L) treatment for advanced NSCLC (aNSCLC) in CheckMate 227 part 1: Efficacy by KRAS, STK11, and KEAP1 mutation status

DOI

25

Citations

0

References

2021

Year

Suresh S. Ramalingam, David Balli, T-E. Ciuleanu, Jin Sun Lee, Michael Schenker, Reyes Bernabé, K.H. Lee, Roberta Bartolucci, Clarisse Audigier-Valette, Matthew D. Hellmann,
Annals of Oncology

No additional data available for this publication yet. Check back later!